CYBIN - The Mushroom Long Term Play

1 mai 2022

Amidst my re-evaluation of markets, divestment from crypto, and future planning, I'm slowly building a long term position in CYBIN. As a therapist who also happens to be a fan of psychedelics, this one fits me well. I think it can continue to flounder around, and perhaps test some even lower levels. Just looking for optimal entry points now, and managed to scoop some up the other day at $0.50. Over the next 10 years, I think the psychedelic mushroom industry will be an interesting place for growth. Screw tech. Mushrooms all the way! And not just the magic ones. I'll be on the lookout for other companies as well, and should probably devote some more time to research.

I placed some theoretical targets for this, since the company is currently valued just under 100M. I think $3 Billion is fairly conservative, hence the $15 target.

This is meant for speculation only, and not as financial advice.

-Victor Cobra

16 août 2022

Note

I want to add here a realistic point of view, and that is - the mushroom industry might end up with the same fate as pot stocks. As more producers enter the market, the cost goes down, not up, while demand moves up much more slowly. So, with not too much cash on hand, CYBIN could be in danger, and perhaps it has already seen its highs.

19 août 2022

Trade fermée manuellement

I sold half my $0.40 position here above $0.92. I’m just taking what I can get in this market, and I’m a little concerned about the company’s finances going into this tough economic situation. I think it could perhaps head higher, but I may not re-enter until we see markets cool down again.

24 août 2022

Trade fermée manuellement

Closed the other half today.

31 oct. 2022

Transaction en cours

Re-entered 3/4ths of the original position here at $0.46-48. Will probably just hold for now. If we see new lows I may buy more or at least look for other opportunities in the space.

9 juin 2023

Note

I ended up selling out of the position at $0.28 and purchasing MindMedicine for this play instead. CYBIN's finances look like crap to me.

10 janv.

Transaction en cours

Ended up getting back in and selling MindMedicine. I thought more about it and it seems CYBIN is a little more poised to succeed in the space. Although may invest again in MIndMed in the future. For now, I’m only allocating a small amount to this market.